Profound hypotension following concomitant administration of tizanidine and lisinopril

被引:0
|
作者
Setzer, Kayla [1 ]
Baldwin, Nicholas [2 ]
Mersfelder, Tracey [3 ]
Kelly, Matthew [4 ]
机构
[1] Western Michigan Univ, Internal Med & Pediat, Homer Stryker MD Sch Med, Kalamazoo, MI 49008 USA
[2] Ferris State Univ, Sch Pharm, Big Rapids, MI USA
[3] Ferris State Univ, Pharm Practice, Big Rapids, MI USA
[4] Western Michigan Univ, Homer Stryker MD Sch Med, Internal Med, Kalamazoo, MI USA
关键词
Drug interactions; Medical management;
D O I
10.1136/bcr-2024-262982
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tizanidine, a muscle relaxant, exerts its mechanism as a centrally acting alpha-2 adrenergic receptor agonist and binds to imidazoline receptors. Bradycardia and hypotension are adverse effects associated with alpha-2 adrenergic receptor agonists. A man in his 50s with a medical history of hypertension and chronic back pain presented with chest pain and hypertension. Pertinent medication history included metoprolol tartrate, lisinopril, hydralazine, hydrochlorothiazide and tizanidine and was continued. Following medication administration, the patient was hypotensive. Further episodes occurred that correlated with tizanidine administration and were more pronounced with concomitant lisinopril administration. Tizanidine was discontinued, and the hypotensive episodes resolved. Profound hypotension caused by a tizanidine-lisinopril drug interaction is rare but potentially life-threatening. This reaction scored a 4 on the Naranjo Adverse Drug Reaction Probability Scale and Drug Interaction Probability Scale. Providers should be aware of this potential adverse reaction from the combination of medications.
引用
收藏
页数:4
相关论文
共 31 条
  • [21] Population Pharmacokinetic Modeling and Simulation of Amprenavir Following Fosamprenavir/Ritonavir Administration for Dose Optimization in HIV Infected Pediatric Patients
    Barbour, April M.
    Gibiansky, Leonid
    Wire, Mary Beth
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (02): : 206 - 214
  • [22] Relationships between concomitant biologic DMARDs and prednisolone administration and blood tacrolimus exposure or serum CYP3A4/5-related markers in rheumatoid arthritis patients
    Naito, Takafumi
    Ohshiro, Junya
    Sato, Hikaru
    Torikai, Eiji
    Suzuki, Motohiro
    Ogawa, Noriyoshi
    Kawakami, Junichi
    CLINICAL BIOCHEMISTRY, 2019, 69 : 8 - 14
  • [23] Concomitant letermovir affects the optimal concentration-to-dose ratio of tacrolimus after switching from intravenous to oral tacrolimus administration in hematopoietic cell transplantation patients receiving fluconazole prophylaxis
    Nakashima, Toshihisa
    Inamoto, Yoshihiro
    Ito, Ayumu
    Kim, Sung-Won
    Fukuda, Takahiro
    Hashimoto, Hironobu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025, 121 (04) : 462 - 466
  • [24] Changes in gefitinib, erlotinib and osimertinib pharmacokinetics under various gastric pH levels following oral administration of omeprazole and vonoprazan in rats
    Yasumuro, Osamu
    Uchida, Shinya
    Kashiwagura, Yasuharu
    Suzuki, Ayae
    Tanaka, Shimako
    Inui, Naoki
    Watanabe, Hiroshi
    Namiki, Noriyuki
    XENOBIOTICA, 2018, 48 (11) : 1106 - 1112
  • [25] Precise simultaneous quantification of methadone and cocaine in rat serum and brain tissue samples following their successive i.p. administration
    Nakhla, David S.
    Hussein, Lobna A.
    Magdy, N.
    Abdallah, Inas A.
    Hassan, Hazem E.
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2017, 1048 : 19 - 29
  • [26] Steady-State Carbamazepine Pharmacokinetics Following Oral and Stable-Labeled Intravenous Administration in Epilepsy Patients: Effects of Race and Sex
    Marino, S. E.
    Birnbaum, A. K.
    Leppik, I. E.
    Conway, J. M.
    Musib, L. C.
    Brundage, R. C.
    Ramsay, R. E.
    Pennell, P. B.
    White, J. R.
    Gross, C. R.
    Rarick, J. O.
    Mishra, U.
    Cloyd, J. C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (03) : 483 - 488
  • [27] Prediction of Losartan-Active Carboxylic Acid Metabolite Exposure Following Losartan Administration Using Static and Physiologically Based Pharmacokinetic Models
    Nguyen, Hoa Q.
    Lin, Jian
    Kimoto, Emi
    Callegari, Ernesto
    Tse, Susanna
    Obach, R. Scott
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (09) : 2758 - 2770
  • [28] THE ABILITY OF FILGRASTIM TO MITIGATE MORTALITY FOLLOWING LD50/60 TOTAL-BODY IRRADIATION IS ADMINISTRATION TIME-DEPENDENT
    Farese, Ann M.
    Brown, Cassandra R.
    Smith, Cassandra P.
    Gibbs, Allison M.
    Katz, Barry P.
    Johnson, Cynthia S.
    Prado, Karl L.
    MacVittie, Thomas J.
    HEALTH PHYSICS, 2014, 106 (01): : 39 - 47
  • [29] Anaphylaxis to Patent Blue V Dye With Clinical Deterioration Following Administration of Suxamethonium and Sensitisation on Skin Testing to Methylene Blue, Patent Blue V Dye and Suxamethonium
    Benison, Edward A.
    Garcez, Tomaz
    Chambers, Lucy
    Parkes, Andrew
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [30] Safety, tolerability, and pharmacokinetics of JX11502MA in Chinese healthy subjects: a first-in-human, randomized, double-blind, placebo-controlled study following single-dose administration
    Yu, Yimin
    He, Jingjing
    Huang, Zhiwei
    Li, Yan
    Wu, Ying
    Shen, Yifeng
    Zhou, Yanling
    Bao, Cungang
    Jin, Zhiping
    Li, Huafang
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (01) : 51 - 61